» Articles » PMID: 31874894

What Factors Contribute to Uncontrolled Gout and Hospital Admission? A Qualitative Study of Inpatients and Their Primary Care Practitioners

Overview
Journal BMJ Open
Specialty General Medicine
Date 2019 Dec 26
PMID 31874894
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To provide deeper insight into why patients are admitted to hospital with gout and discover potential targets for better disease control.

Design: Data from semi-structured interviews were analysed using a thematic analysis approach.

Participants And Setting: Eleven inpatients from a tertiary institution in the Australian Capital Territory of Australia and their respective general practitioners (GPs) were invited to participate in the semi-structured interviews.

Results: Despite significant pain and disability that accompanied acute flares, patients continue to experience shame in seeking treatment and regarded gout as being not particularly important. Other barriers included patients' poor continuity of care with and lack of confidence in GPs, suboptimal management in outpatient and inpatient settings, poor understanding of disease and treatment, and misconceptions held by both patients and physicians leading to uncontrolled disease activity.

Conclusions: Barriers to optimal gout management including patient and health practitioner factors have produced a complex effect which has led to a cycle of treatment avoidance behaviours and recurrent hospitalisations for severe acute gout flares. These barriers could be addressed using a multipronged approach guided by the chronic care model which has been applied in a variety of other chronic diseases with improved patient and professional-level outcomes. Managing gout according to best practice for chronic disease is more likely to prevent recurrent hospitalisations and improve health outcomes in patients with gout.

Citing Articles

Support needs of gout patients and suitability of eHealth to address these needs.

van der Ven J, van den Bemt B, Ariaans F, Vriezekolk J, Flendrie M, Verhoef L Rheumatol Adv Pract. 2024; 8(4):rkae125.

PMID: 39439748 PMC: 11494372. DOI: 10.1093/rap/rkae125.


Moving the Needle in Gout Management: The Role of Culture, Diet, Genetics, and Personalized Patient Care Practices.

Roman Y Nutrients. 2022; 14(17).

PMID: 36079846 PMC: 9460297. DOI: 10.3390/nu14173590.


Hospital admission risk stratification of patients with gout presenting to the emergency department.

Han W, Allameen N, Ibrahim I, Dhanasekaran P, Mengling F, Lahiri M Clin Rheumatol. 2022; 41(6):1801-1807.

PMID: 34973076 PMC: 9119890. DOI: 10.1007/s10067-021-05902-5.


Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) common language definition of gout.

Murdoch R, Barry M, Choi H, Hernandez D, Johnsen B, Labrador M RMD Open. 2021; 7(2).

PMID: 33903281 PMC: 8076916. DOI: 10.1136/rmdopen-2021-001623.

References
1.
Jeyaruban A, Soden M, Larkins S . Prevalence of comorbidities and management of gout in a tropical city in Australia. Rheumatol Int. 2016; 36(12):1753-1758. DOI: 10.1007/s00296-016-3580-6. View

2.
Graf S, Whittle S, Wechalekar M, Moi J, Barrett C, Hill C . Australian and New Zealand recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion in the 3e Initiative. Int J Rheum Dis. 2015; 18(3):341-51. DOI: 10.1111/1756-185X.12557. View

3.
Roddy E, Zhang W, Doherty M . Is gout associated with reduced quality of life? A case-control study. Rheumatology (Oxford). 2007; 46(9):1441-4. DOI: 10.1093/rheumatology/kem150. View

4.
Reynolds R, Dennis S, Hasan I, Slewa J, Chen W, Tian D . A systematic review of chronic disease management interventions in primary care. BMC Fam Pract. 2018; 19(1):11. PMC: 5759778. DOI: 10.1186/s12875-017-0692-3. View

5.
Manara M, Carrara G, Scire C, Cimmino M, Govoni M, Montecucco C . Lifestyle and dietary habits of patients with gout followed in rheumatology settings. Reumatismo. 2016; 67(4):138-48. DOI: 10.4081/reumatismo.2015.861. View